Impulse Control Disorders in Parkinson’s Disease:Management, Controversies, and Potential Approaches
Identifieur interne : 000843 ( Pmc/Curation ); précédent : 000842; suivant : 000844Impulse Control Disorders in Parkinson’s Disease:Management, Controversies, and Potential Approaches
Auteurs : M. Samuel [Royaume-Uni] ; M. Rodriguez-Oroz ; A. Antonini [Italie] ; Jm Brotchie [Canada] ; K. Ray Chaudhuri [Royaume-Uni] ; Rg Brown [Royaume-Uni] ; Wr Galpern [États-Unis] ; Mj Nirenberg [États-Unis] ; Ms Okun [États-Unis] ; Ae Lang [Canada]Source :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2015.
Abstract
Impulse control disorders in Parkinson’s disease are a group of impulsive behaviors most often associated with dopaminergic treatment. Presently, there is a lack of high quality evidence available to guide their management. This manuscript reviews current management strategies, before concentrating on the concept of dopamine agonist withdrawal syndrome and its implications for the management of impulse control disorders. Further, we focus on controversies including the role of more recently available anti-parkinsonian drugs, and potential future approaches involving routes of drug delivery, non-pharmacological treatments (such as cognitive behaviour therapy and deep brain stimulation), and other as yet experimental strategies.
Url:
DOI: 10.1002/mds.26099
PubMed: 25607799
PubMed Central: 5077247
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000843
Links to Exploration step
PMC:5077247Curation
No country items
M. Rodriguez-Oroz<affiliation><nlm:aff id="A2">Department of Neurology, University Hospital Donostia; Neuroscience Unit BioDonostia Research Institute, San Sebastian; Ikerbasque, Basque Foundation for Science, Bilbao; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); Spain</nlm:aff>
<wicri:noCountry code="subfield">Bilbao; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); Spain</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impulse Control Disorders in Parkinson’s Disease:Management, Controversies, and Potential Approaches</title>
<author><name sortKey="Samuel, M" sort="Samuel, M" uniqKey="Samuel M" first="M" last="Samuel">M. Samuel</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Neurology, National Parkinson Foundation International Centre of Excellence, King’s College Hospital, King’s Health Partners, London, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, National Parkinson Foundation International Centre of Excellence, King’s College Hospital, King’s Health Partners, London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rodriguez Oroz, M" sort="Rodriguez Oroz, M" uniqKey="Rodriguez Oroz M" first="M" last="Rodriguez-Oroz">M. Rodriguez-Oroz</name>
<affiliation><nlm:aff id="A2">Department of Neurology, University Hospital Donostia; Neuroscience Unit BioDonostia Research Institute, San Sebastian; Ikerbasque, Basque Foundation for Science, Bilbao; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); Spain</nlm:aff>
<wicri:noCountry code="subfield">Bilbao; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); Spain</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Antonini, A" sort="Antonini, A" uniqKey="Antonini A" first="A" last="Antonini">A. Antonini</name>
<affiliation wicri:level="1"><nlm:aff id="A3">Fondazione Ospedale San Camillo- I.R.C.C.S., Parkinson Unit, Venice, Italy</nlm:aff>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Fondazione Ospedale San Camillo- I.R.C.C.S., Parkinson Unit, Venice</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Brotchie, Jm" sort="Brotchie, Jm" uniqKey="Brotchie J" first="Jm" last="Brotchie">Jm Brotchie</name>
<affiliation wicri:level="1"><nlm:aff id="A4">Toronto Western Research Institute, Toronto Western Hospital, 60 Leonard St, KDT 8-402 Toronto, Ontario, M5T 2S8, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Western Research Institute, Toronto Western Hospital, 60 Leonard St, KDT 8-402 Toronto, Ontario, M5T 2S8</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ray Chaudhuri, K" sort="Ray Chaudhuri, K" uniqKey="Ray Chaudhuri K" first="K" last="Ray Chaudhuri">K. Ray Chaudhuri</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Neurology, National Parkinson Foundation International Centre of Excellence, King’s College Hospital, King’s Health Partners, London, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, National Parkinson Foundation International Centre of Excellence, King’s College Hospital, King’s Health Partners, London</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A5">Department of Clinical Neuroscience, Institute of Psychiatry, King’s College London, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neuroscience, Institute of Psychiatry, King’s College London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Brown, Rg" sort="Brown, Rg" uniqKey="Brown R" first="Rg" last="Brown">Rg Brown</name>
<affiliation wicri:level="1"><nlm:aff id="A6">King’s College London, Institute of Psychiatry, Department of Psychology (PO77) De Crespigny Park, London SE5 8AF, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>King’s College London, Institute of Psychiatry, Department of Psychology (PO77) De Crespigny Park, London SE5 8AF</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Galpern, Wr" sort="Galpern, Wr" uniqKey="Galpern W" first="Wr" last="Galpern">Wr Galpern</name>
<affiliation wicri:level="2"><nlm:aff id="A7">National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Nirenberg, Mj" sort="Nirenberg, Mj" uniqKey="Nirenberg M" first="Mj" last="Nirenberg">Mj Nirenberg</name>
<affiliation wicri:level="2"><nlm:aff id="A8">Department of Neurology, NYU School of Medicine, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Neurology, NYU School of Medicine, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Okun, Ms" sort="Okun, Ms" uniqKey="Okun M" first="Ms" last="Okun">Ms Okun</name>
<affiliation wicri:level="1"><nlm:aff id="A9">UF Center for Movement Disorders and Neurorestoration, 3450 Hull Road, 4th Floor, Gainesville FL 32607, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>UF Center for Movement Disorders and Neurorestoration, 3450 Hull Road, 4th Floor, Gainesville FL 32607</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lang, Ae" sort="Lang, Ae" uniqKey="Lang A" first="Ae" last="Lang">Ae Lang</name>
<affiliation wicri:level="1"><nlm:aff id="A10">Morton and Gloria Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson’s Disease, Toronto Western Hospital, Toronto, ON, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Morton and Gloria Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson’s Disease, Toronto Western Hospital, Toronto, ON</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">25607799</idno>
<idno type="pmc">5077247</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077247</idno>
<idno type="RBID">PMC:5077247</idno>
<idno type="doi">10.1002/mds.26099</idno>
<date when="2015">2015</date>
<idno type="wicri:Area/Pmc/Corpus">000843</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000843</idno>
<idno type="wicri:Area/Pmc/Curation">000843</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000843</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Impulse Control Disorders in Parkinson’s Disease:Management, Controversies, and Potential Approaches</title>
<author><name sortKey="Samuel, M" sort="Samuel, M" uniqKey="Samuel M" first="M" last="Samuel">M. Samuel</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Neurology, National Parkinson Foundation International Centre of Excellence, King’s College Hospital, King’s Health Partners, London, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, National Parkinson Foundation International Centre of Excellence, King’s College Hospital, King’s Health Partners, London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rodriguez Oroz, M" sort="Rodriguez Oroz, M" uniqKey="Rodriguez Oroz M" first="M" last="Rodriguez-Oroz">M. Rodriguez-Oroz</name>
<affiliation><nlm:aff id="A2">Department of Neurology, University Hospital Donostia; Neuroscience Unit BioDonostia Research Institute, San Sebastian; Ikerbasque, Basque Foundation for Science, Bilbao; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); Spain</nlm:aff>
<wicri:noCountry code="subfield">Bilbao; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); Spain</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Antonini, A" sort="Antonini, A" uniqKey="Antonini A" first="A" last="Antonini">A. Antonini</name>
<affiliation wicri:level="1"><nlm:aff id="A3">Fondazione Ospedale San Camillo- I.R.C.C.S., Parkinson Unit, Venice, Italy</nlm:aff>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Fondazione Ospedale San Camillo- I.R.C.C.S., Parkinson Unit, Venice</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Brotchie, Jm" sort="Brotchie, Jm" uniqKey="Brotchie J" first="Jm" last="Brotchie">Jm Brotchie</name>
<affiliation wicri:level="1"><nlm:aff id="A4">Toronto Western Research Institute, Toronto Western Hospital, 60 Leonard St, KDT 8-402 Toronto, Ontario, M5T 2S8, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Western Research Institute, Toronto Western Hospital, 60 Leonard St, KDT 8-402 Toronto, Ontario, M5T 2S8</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ray Chaudhuri, K" sort="Ray Chaudhuri, K" uniqKey="Ray Chaudhuri K" first="K" last="Ray Chaudhuri">K. Ray Chaudhuri</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Neurology, National Parkinson Foundation International Centre of Excellence, King’s College Hospital, King’s Health Partners, London, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, National Parkinson Foundation International Centre of Excellence, King’s College Hospital, King’s Health Partners, London</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A5">Department of Clinical Neuroscience, Institute of Psychiatry, King’s College London, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neuroscience, Institute of Psychiatry, King’s College London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Brown, Rg" sort="Brown, Rg" uniqKey="Brown R" first="Rg" last="Brown">Rg Brown</name>
<affiliation wicri:level="1"><nlm:aff id="A6">King’s College London, Institute of Psychiatry, Department of Psychology (PO77) De Crespigny Park, London SE5 8AF, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>King’s College London, Institute of Psychiatry, Department of Psychology (PO77) De Crespigny Park, London SE5 8AF</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Galpern, Wr" sort="Galpern, Wr" uniqKey="Galpern W" first="Wr" last="Galpern">Wr Galpern</name>
<affiliation wicri:level="2"><nlm:aff id="A7">National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Nirenberg, Mj" sort="Nirenberg, Mj" uniqKey="Nirenberg M" first="Mj" last="Nirenberg">Mj Nirenberg</name>
<affiliation wicri:level="2"><nlm:aff id="A8">Department of Neurology, NYU School of Medicine, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Neurology, NYU School of Medicine, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Okun, Ms" sort="Okun, Ms" uniqKey="Okun M" first="Ms" last="Okun">Ms Okun</name>
<affiliation wicri:level="1"><nlm:aff id="A9">UF Center for Movement Disorders and Neurorestoration, 3450 Hull Road, 4th Floor, Gainesville FL 32607, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>UF Center for Movement Disorders and Neurorestoration, 3450 Hull Road, 4th Floor, Gainesville FL 32607</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lang, Ae" sort="Lang, Ae" uniqKey="Lang A" first="Ae" last="Lang">Ae Lang</name>
<affiliation wicri:level="1"><nlm:aff id="A10">Morton and Gloria Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson’s Disease, Toronto Western Hospital, Toronto, ON, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Morton and Gloria Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson’s Disease, Toronto Western Hospital, Toronto, ON</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2015">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P1">Impulse control disorders in Parkinson’s disease are a group of impulsive behaviors most often associated with dopaminergic treatment. Presently, there is a lack of high quality evidence available to guide their management. This manuscript reviews current management strategies, before concentrating on the concept of dopamine agonist withdrawal syndrome and its implications for the management of impulse control disorders. Further, we focus on controversies including the role of more recently available anti-parkinsonian drugs, and potential future approaches involving routes of drug delivery, non-pharmacological treatments (such as cognitive behaviour therapy and deep brain stimulation), and other as yet experimental strategies.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">8610688</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5937</journal-id>
<journal-id journal-id-type="nlm-ta">Mov Disord</journal-id>
<journal-id journal-id-type="iso-abbrev">Mov. Disord.</journal-id>
<journal-title-group><journal-title>Movement disorders : official journal of the Movement Disorder Society</journal-title>
</journal-title-group>
<issn pub-type="ppub">0885-3185</issn>
<issn pub-type="epub">1531-8257</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">25607799</article-id>
<article-id pub-id-type="pmc">5077247</article-id>
<article-id pub-id-type="doi">10.1002/mds.26099</article-id>
<article-id pub-id-type="manuscript">NIHMS641565</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Impulse Control Disorders in Parkinson’s Disease:Management, Controversies, and Potential Approaches</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Samuel</surname>
<given-names>M</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Rodriguez-Oroz</surname>
<given-names>M</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Antonini</surname>
<given-names>A</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Brotchie</surname>
<given-names>JM</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Ray Chaudhuri</surname>
<given-names>K</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Brown</surname>
<given-names>RG</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Galpern</surname>
<given-names>WR</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Nirenberg</surname>
<given-names>MJ</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Okun</surname>
<given-names>MS</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Lang</surname>
<given-names>AE</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>
Department of Neurology, National Parkinson Foundation International Centre of Excellence, King’s College Hospital, King’s Health Partners, London, UK</aff>
<aff id="A2"><label>2</label>
Department of Neurology, University Hospital Donostia; Neuroscience Unit BioDonostia Research Institute, San Sebastian; Ikerbasque, Basque Foundation for Science, Bilbao; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); Spain</aff>
<aff id="A3"><label>3</label>
Fondazione Ospedale San Camillo- I.R.C.C.S., Parkinson Unit, Venice, Italy</aff>
<aff id="A4"><label>4</label>
Toronto Western Research Institute, Toronto Western Hospital, 60 Leonard St, KDT 8-402 Toronto, Ontario, M5T 2S8, Canada</aff>
<aff id="A5"><label>5</label>
Department of Clinical Neuroscience, Institute of Psychiatry, King’s College London, UK</aff>
<aff id="A6"><label>6</label>
King’s College London, Institute of Psychiatry, Department of Psychology (PO77) De Crespigny Park, London SE5 8AF, UK</aff>
<aff id="A7"><label>7</label>
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD USA</aff>
<aff id="A8"><label>8</label>
Department of Neurology, NYU School of Medicine, New York, NY</aff>
<aff id="A9"><label>9</label>
UF Center for Movement Disorders and Neurorestoration, 3450 Hull Road, 4th Floor, Gainesville FL 32607, USA</aff>
<aff id="A10"><label>10</label>
Morton and Gloria Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson’s Disease, Toronto Western Hospital, Toronto, ON, Canada</aff>
<pub-date pub-type="nihms-submitted"><day>14</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub"><day>21</day>
<month>1</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub"><month>2</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>24</day>
<month>10</month>
<year>2016</year>
</pub-date>
<volume>30</volume>
<issue>2</issue>
<fpage>150</fpage>
<lpage>159</lpage>
<pmc-comment>elocation-id from pubmed: 10.1002/mds.26099</pmc-comment>
<abstract><p id="P1">Impulse control disorders in Parkinson’s disease are a group of impulsive behaviors most often associated with dopaminergic treatment. Presently, there is a lack of high quality evidence available to guide their management. This manuscript reviews current management strategies, before concentrating on the concept of dopamine agonist withdrawal syndrome and its implications for the management of impulse control disorders. Further, we focus on controversies including the role of more recently available anti-parkinsonian drugs, and potential future approaches involving routes of drug delivery, non-pharmacological treatments (such as cognitive behaviour therapy and deep brain stimulation), and other as yet experimental strategies.</p>
</abstract>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000843 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000843 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Pmc |étape= Curation |type= RBID |clé= PMC:5077247 |texte= Impulse Control Disorders in Parkinson’s Disease:Management, Controversies, and Potential Approaches }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:25607799" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonCanadaV1
This area was generated with Dilib version V0.6.29. |